Associated Papers
Deep CRISPR mutagenesis characterizes the functional diversity of TP53 mutations.
Funk JS et al.
Nature Genetics, 2025
39774325 (PubMed )
Supplement: 41588_2024_2039_MOESM9_ESM.xlsx › Fig4c
Genetics of breast cancer in African populations: a literature review.
Abbad A et al.
Global Health, Epidemiology and Genomics, 2018
BRCA genetic screening in Middle Eastern and North African: mutational spectrum and founder BRCA1 mutation (c.798_799delTT) in North African.
Laraqui A et al.
Disease Markers, 2015
Hereditary breast cancer in Middle Eastern and North African (MENA) populations: identification of novel, recurrent and founder BRCA1 mutations in the Tunisian population.
Mahfoudh W et al.
Molecular Biology Reports, 2012
Germline mutations of TP53 and BRCA2 genes in breast cancer/sarcoma families.
Manoukian S et al.
European Journal of Cancer (oxford, England : 1990), 2007
[Mutational analysis of breast/ovarian cancer hereditary predisposition gene BRCA1 in Tunisian women].
Mestiri S et al.
Archives De L'institut Pasteur De Tunis, 2000
Select a paper to view details